Phenolic Novolac
Phenolic Novolac market is segmented by Type and by Application. Players, stakeholders, and other ... Read More
Global OTC Drug Market Insights and Forecast to 2031
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Class A OTC Drug
1.2.3 Class B OTC Drug
1.3 Market by Application
1.3.1 Global OTC Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global OTC Drug Market Perspective (2017-2028)
2.2 OTC Drug Growth Trends by Region
2.2.1 OTC Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 OTC Drug Historic Market Size by Region (2017-2022)
2.2.3 OTC Drug Forecasted Market Size by Region (2023-2028)
2.3 OTC Drug Market Dynamics
2.3.1 OTC Drug Industry Trends
2.3.2 OTC Drug Market Drivers
2.3.3 OTC Drug Market Challenges
2.3.4 OTC Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Drug Players by Revenue
3.1.1 Global Top OTC Drug Players by Revenue (2017-2022)
3.1.2 Global OTC Drug Revenue Market Share by Players (2017-2022)
3.2 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Drug Revenue
3.4 Global OTC Drug Market Concentration Ratio
3.4.1 Global OTC Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Drug Revenue in 2021
3.5 OTC Drug Key Players Head office and Area Served
3.6 Key Players OTC Drug Product Solution and Service
3.7 Date of Enter into OTC Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Drug Breakdown Data by Type
4.1 Global OTC Drug Historic Market Size by Type (2017-2022)
4.2 Global OTC Drug Forecasted Market Size by Type (2023-2028)
5 OTC Drug Breakdown Data by Application
5.1 Global OTC Drug Historic Market Size by Application (2017-2022)
5.2 Global OTC Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America OTC Drug Market Size (2017-2028)
6.2 North America OTC Drug Market Size by Type
6.2.1 North America OTC Drug Market Size by Type (2017-2022)
6.2.2 North America OTC Drug Market Size by Type (2023-2028)
6.2.3 North America OTC Drug Market Share by Type (2017-2028)
6.3 North America OTC Drug Market Size by Application
6.3.1 North America OTC Drug Market Size by Application (2017-2022)
6.3.2 North America OTC Drug Market Size by Application (2023-2028)
6.3.3 North America OTC Drug Market Share by Application (2017-2028)
6.4 North America OTC Drug Market Size by Country
6.4.1 North America OTC Drug Market Size by Country (2017-2022)
6.4.2 North America OTC Drug Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe OTC Drug Market Size (2017-2028)
7.2 Europe OTC Drug Market Size by Type
7.2.1 Europe OTC Drug Market Size by Type (2017-2022)
7.2.2 Europe OTC Drug Market Size by Type (2023-2028)
7.2.3 Europe OTC Drug Market Share by Type (2017-2028)
7.3 Europe OTC Drug Market Size by Application
7.3.1 Europe OTC Drug Market Size by Application (2017-2022)
7.3.2 Europe OTC Drug Market Size by Application (2023-2028)
7.3.3 Europe OTC Drug Market Share by Application (2017-2028)
7.4 Europe OTC Drug Market Size by Country
7.4.1 Europe OTC Drug Market Size by Country (2017-2022)
7.4.2 Europe OTC Drug Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Drug Market Size (2017-2028)
8.2 Asia-Pacific OTC Drug Market Size by Type
8.2.1 Asia-Pacific OTC Drug Market Size by Type (2017-2022)
8.2.2 Asia-Pacific OTC Drug Market Size by Type (2023-2028)
8.2.3 Asia-Pacific OTC Drug Market Share by Type (2017-2028)
8.3 Asia-Pacific OTC Drug Market Size by Application
8.3.1 Asia-Pacific OTC Drug Market Size by Application (2017-2022)
8.3.2 Asia-Pacific OTC Drug Market Size by Application (2023-2028)
8.3.3 Asia-Pacific OTC Drug Market Share by Application (2017-2028)
8.4 Asia-Pacific OTC Drug Market Size by Region
8.4.1 Asia-Pacific OTC Drug Market Size by Region (2017-2022)
8.4.2 Asia-Pacific OTC Drug Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America OTC Drug Market Size (2017-2028)
9.2 Latin America OTC Drug Market Size by Type
9.2.1 Latin America OTC Drug Market Size by Type (2017-2022)
9.2.2 Latin America OTC Drug Market Size by Type (2023-2028)
9.2.3 Latin America OTC Drug Market Share by Type (2017-2028)
9.3 Latin America OTC Drug Market Size by Application
9.3.1 Latin America OTC Drug Market Size by Application (2017-2022)
9.3.2 Latin America OTC Drug Market Size by Application (2023-2028)
9.3.3 Latin America OTC Drug Market Share by Application (2017-2028)
9.4 Latin America OTC Drug Market Size by Country
9.4.1 Latin America OTC Drug Market Size by Country (2017-2022)
9.4.2 Latin America OTC Drug Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Drug Market Size (2017-2028)
10.2 Middle East & Africa OTC Drug Market Size by Type
10.2.1 Middle East & Africa OTC Drug Market Size by Type (2017-2022)
10.2.2 Middle East & Africa OTC Drug Market Size by Type (2023-2028)
10.2.3 Middle East & Africa OTC Drug Market Share by Type (2017-2028)
10.3 Middle East & Africa OTC Drug Market Size by Application
10.3.1 Middle East & Africa OTC Drug Market Size by Application (2017-2022)
10.3.2 Middle East & Africa OTC Drug Market Size by Application (2023-2028)
10.3.3 Middle East & Africa OTC Drug Market Share by Application (2017-2028)
10.4 Middle East & Africa OTC Drug Market Size by Country
10.4.1 Middle East & Africa OTC Drug Market Size by Country (2017-2022)
10.4.2 Middle East & Africa OTC Drug Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Details
11.1.2 Bayer HealthCare Business Overview
11.1.3 Bayer HealthCare OTC Drug Introduction
11.1.4 Bayer HealthCare Revenue in OTC Drug Business (2017-2022)
11.1.5 Bayer HealthCare Recent Developments
11.2 GlaxoSmithKline(GSK)
11.2.1 GlaxoSmithKline(GSK) Company Details
11.2.2 GlaxoSmithKline(GSK) Business Overview
11.2.3 GlaxoSmithKline(GSK) OTC Drug Introduction
11.2.4 GlaxoSmithKline(GSK) Revenue in OTC Drug Business (2017-2022)
11.2.5 GlaxoSmithKline(GSK) Recent Developments
11.3 Johnson&Johnson
11.3.1 Johnson&Johnson Company Details
11.3.2 Johnson&Johnson Business Overview
11.3.3 Johnson&Johnson OTC Drug Introduction
11.3.4 Johnson&Johnson Revenue in OTC Drug Business (2017-2022)
11.3.5 Johnson&Johnson Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer OTC Drug Introduction
11.4.4 Pfizer Revenue in OTC Drug Business (2017-2022)
11.4.5 Pfizer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi OTC Drug Introduction
11.5.4 Sanofi Revenue in OTC Drug Business (2017-2022)
11.5.5 Sanofi Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca OTC Drug Introduction
11.6.4 AstraZeneca Revenue in OTC Drug Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 BioGaia
11.7.1 BioGaia Company Details
11.7.2 BioGaia Business Overview
11.7.3 BioGaia OTC Drug Introduction
11.7.4 BioGaia Revenue in OTC Drug Business (2017-2022)
11.7.5 BioGaia Recent Developments
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Details
11.8.2 Bristol Myers Squibb Business Overview
11.8.3 Bristol Myers Squibb OTC Drug Introduction
11.8.4 Bristol Myers Squibb Revenue in OTC Drug Business (2017-2022)
11.8.5 Bristol Myers Squibb Recent Developments
11.9 Bukwang Pharmaceutica
11.9.1 Bukwang Pharmaceutica Company Details
11.9.2 Bukwang Pharmaceutica Business Overview
11.9.3 Bukwang Pharmaceutica OTC Drug Introduction
11.9.4 Bukwang Pharmaceutica Revenue in OTC Drug Business (2017-2022)
11.9.5 Bukwang Pharmaceutica Recent Developments
11.10 Chr. Hansen
11.10.1 Chr. Hansen Company Details
11.10.2 Chr. Hansen Business Overview
11.10.3 Chr. Hansen OTC Drug Introduction
11.10.4 Chr. Hansen Revenue in OTC Drug Business (2017-2022)
11.10.5 Chr. Hansen Recent Developments
11.11 Cipla
11.11.1 Cipla Company Details
11.11.2 Cipla Business Overview
11.11.3 Cipla OTC Drug Introduction
11.11.4 Cipla Revenue in OTC Drug Business (2017-2022)
11.11.5 Cipla Recent Developments
11.12 CoLucid
11.12.1 CoLucid Company Details
11.12.2 CoLucid Business Overview
11.12.3 CoLucid OTC Drug Introduction
11.12.4 CoLucid Revenue in OTC Drug Business (2017-2022)
11.12.5 CoLucid Recent Developments
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Details
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo OTC Drug Introduction
11.13.4 Daiichi Sankyo Revenue in OTC Drug Business (2017-2022)
11.13.5 Daiichi Sankyo Recent Developments
11.14 Friggs
11.14.1 Friggs Company Details
11.14.2 Friggs Business Overview
11.14.3 Friggs OTC Drug Introduction
11.14.4 Friggs Revenue in OTC Drug Business (2017-2022)
11.14.5 Friggs Recent Developments
11.15 DSM
11.15.1 DSM Company Details
11.15.2 DSM Business Overview
11.15.3 DSM OTC Drug Introduction
11.15.4 DSM Revenue in OTC Drug Business (2017-2022)
11.15.5 DSM Recent Developments
11.16 Eisai
11.16.1 Eisai Company Details
11.16.2 Eisai Business Overview
11.16.3 Eisai OTC Drug Introduction
11.16.4 Eisai Revenue in OTC Drug Business (2017-2022)
11.16.5 Eisai Recent Developments
11.17 Eli Lilly
11.17.1 Eli Lilly Company Details
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly OTC Drug Introduction
11.17.4 Eli Lilly Revenue in OTC Drug Business (2017-2022)
11.17.5 Eli Lilly Recent Developments
11.18 Herbalife
11.18.1 Herbalife Company Details
11.18.2 Herbalife Business Overview
11.18.3 Herbalife OTC Drug Introduction
11.18.4 Herbalife Revenue in OTC Drug Business (2017-2022)
11.18.5 Herbalife Recent Developments
11.19 Euradite
11.19.1 Euradite Company Details
11.19.2 Euradite Business Overview
11.19.3 Euradite OTC Drug Introduction
11.19.4 Euradite Revenue in OTC Drug Business (2017-2022)
11.19.5 Euradite Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global OTC Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Class A OTC Drug
Table 3. Key Players of Class B OTC Drug
Table 4. Global OTC Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global OTC Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global OTC Drug Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global OTC Drug Market Share by Region (2017-2022)
Table 8. Global OTC Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global OTC Drug Market Share by Region (2023-2028)
Table 10. OTC Drug Market Trends
Table 11. OTC Drug Market Drivers
Table 12. OTC Drug Market Challenges
Table 13. OTC Drug Market Restraints
Table 14. Global OTC Drug Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global OTC Drug Revenue Share by Players (2017-2022)
Table 16. Global Top OTC Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Drug as of 2021)
Table 17. Ranking of Global Top OTC Drug Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by OTC Drug Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players OTC Drug Product Solution and Service
Table 21. Date of Enter into OTC Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global OTC Drug Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global OTC Drug Revenue Market Share by Type (2017-2022)
Table 25. Global OTC Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global OTC Drug Revenue Market Share by Type (2023-2028)
Table 27. Global OTC Drug Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global OTC Drug Revenue Share by Application (2017-2022)
Table 29. Global OTC Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global OTC Drug Revenue Share by Application (2023-2028)
Table 31. North America OTC Drug Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America OTC Drug Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America OTC Drug Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America OTC Drug Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America OTC Drug Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America OTC Drug Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe OTC Drug Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe OTC Drug Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe OTC Drug Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe OTC Drug Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe OTC Drug Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe OTC Drug Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific OTC Drug Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific OTC Drug Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific OTC Drug Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific OTC Drug Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific OTC Drug Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific OTC Drug Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America OTC Drug Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America OTC Drug Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America OTC Drug Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America OTC Drug Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America OTC Drug Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America OTC Drug Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa OTC Drug Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa OTC Drug Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa OTC Drug Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa OTC Drug Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa OTC Drug Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa OTC Drug Market Size by Country (2023-2028) & (US$ Million)
Table 61. Bayer HealthCare Company Details
Table 62. Bayer HealthCare Business Overview
Table 63. Bayer HealthCare OTC Drug Product
Table 64. Bayer HealthCare Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 65. Bayer HealthCare Recent Developments
Table 66. GlaxoSmithKline(GSK) Company Details
Table 67. GlaxoSmithKline(GSK) Business Overview
Table 68. GlaxoSmithKline(GSK) OTC Drug Product
Table 69. GlaxoSmithKline(GSK) Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 70. GlaxoSmithKline(GSK) Recent Developments
Table 71. Johnson&Johnson Company Details
Table 72. Johnson&Johnson Business Overview
Table 73. Johnson&Johnson OTC Drug Product
Table 74. Johnson&Johnson Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 75. Johnson&Johnson Recent Developments
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer OTC Drug Product
Table 79. Pfizer Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 80. Pfizer Recent Developments
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi OTC Drug Product
Table 84. Sanofi Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 85. Sanofi Recent Developments
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca OTC Drug Product
Table 89. AstraZeneca Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 90. AstraZeneca Recent Developments
Table 91. BioGaia Company Details
Table 92. BioGaia Business Overview
Table 93. BioGaia OTC Drug Product
Table 94. BioGaia Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 95. BioGaia Recent Developments
Table 96. Bristol Myers Squibb Company Details
Table 97. Bristol Myers Squibb Business Overview
Table 98. Bristol Myers Squibb OTC Drug Product
Table 99. Bristol Myers Squibb Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 100. Bristol Myers Squibb Recent Developments
Table 101. Bukwang Pharmaceutica Company Details
Table 102. Bukwang Pharmaceutica Business Overview
Table 103. Bukwang Pharmaceutica OTC Drug Product
Table 104. Bukwang Pharmaceutica Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 105. Bukwang Pharmaceutica Recent Developments
Table 106. Chr. Hansen Company Details
Table 107. Chr. Hansen Business Overview
Table 108. Chr. Hansen OTC Drug Product
Table 109. Chr. Hansen Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 110. Chr. Hansen Recent Developments
Table 111. Cipla Company Details
Table 112. Cipla Business Overview
Table 113. Cipla OTC Drug Product
Table 114. Cipla Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 115. Cipla Recent Developments
Table 116. CoLucid Company Details
Table 117. CoLucid Business Overview
Table 118. CoLucid OTC Drug Product
Table 119. CoLucid Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 120. CoLucid Recent Developments
Table 121. Daiichi Sankyo Company Details
Table 122. Daiichi Sankyo Business Overview
Table 123. Daiichi Sankyo OTC Drug Product
Table 124. Daiichi Sankyo Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 125. Daiichi Sankyo Recent Developments
Table 126. Friggs Company Details
Table 127. Friggs Business Overview
Table 128. Friggs OTC Drug Product
Table 129. Friggs Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 130. Friggs Recent Developments
Table 131. DSM Company Details
Table 132. DSM Business Overview
Table 133. DSM OTC Drug Product
Table 134. DSM Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 135. DSM Recent Developments
Table 136. Eisai Company Details
Table 137. Eisai Business Overview
Table 138. Eisai OTC Drug Product
Table 139. Eisai Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 140. Eisai Recent Developments
Table 141. Eli Lilly Company Details
Table 142. Eli Lilly Business Overview
Table 143. Eli Lilly OTC Drug Product
Table 144. Eli Lilly Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 145. Eli Lilly Recent Developments
Table 146. Herbalife Company Details
Table 147. Herbalife Business Overview
Table 148. Herbalife OTC Drug Product
Table 149. Herbalife Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 150. Herbalife Recent Developments
Table 151. Euradite Company Details
Table 152. Euradite Business Overview
Table 153. Euradite OTC Drug Product
Table 154. Euradite Revenue in OTC Drug Business (2017-2022) & (US$ Million)
Table 155. Euradite Recent Developments
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Drug Market Share by Type: 2021 VS 2028
Figure 2. Class A OTC Drug Features
Figure 3. Class B OTC Drug Features
Figure 4. Global OTC Drug Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Household Case Studies
Figure 8. OTC Drug Report Years Considered
Figure 9. Global OTC Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global OTC Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global OTC Drug Market Share by Region: 2021 VS 2028
Figure 12. Global OTC Drug Market Share by Players in 2021
Figure 13. Global Top OTC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Drug as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by OTC Drug Revenue in 2021
Figure 15. North America OTC Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America OTC Drug Market Size Market Share by Type (2017-2028)
Figure 17. North America OTC Drug Market Size Market Share by Application (2017-2028)
Figure 18. North America OTC Drug Market Size Share by Country (2017-2028)
Figure 19. United States OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe OTC Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe OTC Drug Market Size Market Share by Type (2017-2028)
Figure 23. Europe OTC Drug Market Size Market Share by Application (2017-2028)
Figure 24. Europe OTC Drug Market Size Share by Country (2017-2028)
Figure 25. Germany OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific OTC Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific OTC Drug Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific OTC Drug Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific OTC Drug Market Size Share by Region (2017-2028)
Figure 35. China OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America OTC Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America OTC Drug Market Size Market Share by Type (2017-2028)
Figure 43. Latin America OTC Drug Market Size Market Share by Application (2017-2028)
Figure 44. Latin America OTC Drug Market Size Share by Country (2017-2028)
Figure 45. Mexico OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa OTC Drug Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa OTC Drug Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa OTC Drug Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa OTC Drug Market Size Share by Country (2017-2028)
Figure 51. Turkey OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE OTC Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Bayer HealthCare Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 55. GlaxoSmithKline(GSK) Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 56. Johnson&Johnson Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 58. Sanofi Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 59. AstraZeneca Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 60. BioGaia Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 61. Bristol Myers Squibb Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 62. Bukwang Pharmaceutica Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 63. Chr. Hansen Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 64. Cipla Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 65. CoLucid Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 66. Daiichi Sankyo Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 67. Friggs Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 68. DSM Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 69. Eisai Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 70. Eli Lilly Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 71. Herbalife Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 72. Euradite Revenue Growth Rate in OTC Drug Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer HealthCare GlaxoSmithKline(GSK) Johnson&Johnson Pfizer Sanofi AstraZeneca BioGaia Bristol Myers Squibb Bukwang Pharmaceutica Chr. Hansen Cipla CoLucid Daiichi Sankyo Friggs DSM Eisai Eli Lilly Herbalife Euradite